Regulation of the Escherichia coli HipBA toxin-antitoxin system by proteolysis

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Hansen, Sonja ^a   Vulić, Marin ^a   Min, Jungki ^b   Yen, Tien Jui ^b   Schumacher, Maria A ^b   Brennan, Richard G ^b   Lewis, Kim ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANTITOXIN; BACTERIAL TOXIN; ENDOPEPTIDASE LA; HIGH PERSISTER A TOXIN; HIGH PERSISTER B ANTITOXIN; TRYPTOPHAN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BACTERIAL STRAIN; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA BINDING; ENZYME SUBSTRATE; ENZYME SUBSTRATE COMPLEX; ESCHERICHIA COLI; FLUORESCENCE POLARIZATION IMMUNOASSAY; IN VITRO STUDY; NONHUMAN; OPERATOR GENE; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN SYNTHESIS INHIBITION; TOXIN STRUCTURE; TOXIN SYNTHESIS;

ANTITOXINS; BACTERIAL TOXINS; BASE SEQUENCE; DNA PRIMERS; ESCHERICHIA COLI; PROTEOLYSIS;

EID: 84862505694     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039185     Document Type: Article

References (59)

1. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S, (2004) Bacterial persistence as a phenotypic switch. Science 305: 1622-1625.
2. Bigger JW, (1944) Treatment of staphylococcal infections with penicillin. Lancet ii: 497-500.
3. Lewis K, (2007) Persister cells, dormancy and infectious disease. Nat Rev Microbiol 5: 48-56.
4. Lewis K, (2010) Persister Cells. Annu Rev Microbiol.
5. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K, (2004) Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 230: 13-18.
6. Wiuff C, Zappala RM, Regoes RR, Garner KN, Baquero F, et al. (2005) Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations. Antimicrob Agents Chemother 49: 1483-1494.
7. Brooun A, Liu S, Lewis K, (2000) A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 44: 640-646.
8. Spoering AL, Lewis K, (2001) Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol 183: 6746-6751.
9. LaFleur MD, Qi Q, Lewis K, (2010) Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob Agents Chemother 54: 39-44.
10. Black DS, Irwin B, Moyed HS, (1994) Autoregulation of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis. J Bacteriol 176: 4081-4091.
11. Black DS, Kelly AJ, Mardis MJ, Moyed HS, (1991) Structure and organization of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis. J Bacteriol 173: 5732-5739.
12. Moyed HS, Bertrand KP, (1983) hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol 155: 768-775.
13. Moyed HS, Broderick SH, (1986) Molecular cloning and expression of hipA, a gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol 166: 399-403.
14. Scherrer R, Moyed HS, (1988) Conditional impairment of cell division and altered lethality in hipA mutants of Escherichia coli K-12. J Bacteriol 170: 3321-3326.
15. Schumacher MA, Piro KM, Xu W, Hansen S, Lewis K, et al. (2009) Molecular mechanisms of HipA-mediated multidrug tolerance and its neutralization by HipB. Science 323: 396-401.
16. Correia FF, D'Onofrio A, Rejtar T, Li L, Karger BL, et al. (2006) Kinase activity of overexpressed HipA is required for growth arrest and multidrug tolerance in Escherichia coli. J Bacteriol 188: 8360-8367.
17. Hansen S, Lewis K, Vulić M, (2008) The role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob Agents Chemother.
18. Korch SB, Henderson TA, Hill TM, (2003) Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis. Mol Microbiol 50: 1199-1213.
19. Korch SB, Hill TM, (2006) Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J Bacteriol 188: 3826-3836.
20. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K, (2004) Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 186: 8172-8180.
21. Maisonneuve E, Shakespeare LJ, Jorgensen MG, Gerdes K, (2011) Bacterial persistence by RNA endonucleases. Proc Natl Acad Sci U S A.
22. Buts L, Lah J, Dao-Thi MH, Wyns L, Loris R, (2005) Toxin-antitoxin modules as bacterial metabolic stress managers. Trends Biochem Sci 30: 672-679.
23. Dorr T, Vulic M, Lewis K, (2010) Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. Plos Biol 8: e1000317.
24. Gerdes K, Christensen SK, Lobner-Olesen A, (2005) Prokaryotic toxin-antitoxin stress response loci. Nat Rev Microbiol 3: 371-382.
25. Jorgensen MG, Pandey DP, Jaskolska M, Gerdes K, (2009) HicA of Escherichia coli defines a novel family of translation-independent mRNA interferases in bacteria and archaea. J Bacteriol 191: 1191-1199.
26. Winther KS, Gerdes K, (2009) Ectopic production of VapCs from Enterobacteria inhibits translation and trans-activates YoeB mRNA interferase. Mol Microbiol 72: 918-930.
27. Arcus VL, Rainey PB, Turner SJ, (2005) The PIN-domain toxin-antitoxin array in mycobacteria. Trends Microbiol 13: 360-365.
28. Christensen SK, Pedersen K, Hansen FG, Gerdes K, (2003) Toxin-antitoxin loci as stress-response-elements: ChpAK/MazF and ChpBK cleave translated RNAs and are counteracted by tmRNA. J Mol Biol 332: 809-819.
29. Prysak MH, Mozdzierz CJ, Cook AM, Zhu L, Zhang Y, et al. (2009) Bacterial toxin YafQ is an endoribonuclease that associates with the ribosome and blocks translation elongation through sequence-specific and frame-dependent mRNA cleavage. Mol Microbiol 71: 1071-1087.
30. Wang X, Kim Y, Hong SH, Ma Q, Brown BL, et al. (2011) Antitoxin MqsA helps mediate the bacterial general stress response. Nat Chem Biol 7: 359-366.
31. Cherny I, Overgaard M, Borch J, Bram Y, Gerdes K, et al. (2007) Structural and thermodynamic characterization of the Escherichia coli RelBE toxin-antitoxin system: indication for a functional role of differential stability. Biochemistry 46: 12152-12163.
32. Garcia-Pino A, Christensen-Dalsgaard M, Wyns L, Yarmolinsky M, Magnuson RD, et al. (2008) Doc of prophage P1 is inhibited by its antitoxin partner Phd through fold complementation. J Biol Chem 283: 30821-30827.
33. Kamada K, Hanaoka F, Burley SK, (2003) Crystal structure of the MazE/MazF complex: molecular bases of antidote-toxin recognition. Mol Cell 11: 875-884.
34. Takagi H, Kakuta Y, Okada T, Yao M, Tanaka I, et al. (2005) Crystal structure of archaeal toxin-antitoxin RelE-RelB complex with implications for toxin activity and antitoxin effects. Nat Struct Mol Biol 12: 327-331.
35. Dienemann C, Boggild A, Winther KS, Gerdes K, Brodersen DE, (2011) Crystal structure of the VapBC toxin-antitoxin complex from Shigella flexneri reveals a hetero-octameric DNA-binding assembly. J Mol Biol 414: 713-722.
36. Kamada K, Hanaoka F, (2005) Conformational change in the catalytic site of the ribonuclease YoeB toxin by YefM antitoxin. Mol Cell 19: 497-509.
37. Mattison K, Wilbur JS, So M, Brennan RG, (2006) Structure of FitAB from Neisseria gonorrhoeae bound to DNA reveals a tetramer of toxin-antitoxin heterodimers containing pin domains and ribbon-helix-helix motifs. J Biol Chem 281: 37942-37951.
38. Christensen SK, Mikkelsen M, Pedersen K, Gerdes K, (2001) RelE, a global inhibitor of translation, is activated during nutritional stress. Proc Natl Acad Sci U S A 98: 14328-14333.
39. Overgaard M, Borch J, Gerdes K, (2009) RelB and RelE of Escherichia coli form a tight complex that represses transcription via the ribbon-helix-helix motif in RelB. J Mol Biol 394: 183-196.
40. Charette MF, Henderson GW, Markovitz A, (1981) ATP hydrolysis-dependent protease activity of the lon (capR) protein of Escherichia coli K-12. Proc Natl Acad Sci U S A 78: 4728-4732.
41. Evdokimov A, Voznesensky I, Fennell K, Anderson M, Smith JF, et al. (2009) New kinase regulation mechanism found in HipBA: a bacterial persistence switch. Acta Crystallogr D Biol Crystallogr 65: 875-879.
42. Tsilibaris V, Maenhaut-Michel G, Van Melderen L, (2006) Biological roles of the Lon ATP-dependent protease. Res Microbiol 157: 701-713.
43. Van Melderen L, Aertsen A, (2009) Regulation and quality control by Lon-dependent proteolysis. Res Microbiol 160: 645-651.
44. Kuroda A, Nomura K, Ohtomo R, Kato J, Ikeda T, et al. (2001) Role of inorganic polyphosphate in promoting ribosomal protein degradation by the Lon protease in E. coli. Science 293: 705-708.
45. Nomura K, Kato J, Takiguchi N, Ohtake H, Kuroda A, (2004) Effects of inorganic polyphosphate on the proteolytic and DNA-binding activities of Lon in Escherichia coli. J Biol Chem 279: 34406-34410.
46. Rotem E, Loinger A, Ronin I, Levin-Reisman I, Gabay C, et al. (2010) Regulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence. Proc Natl Acad Sci U S A 107: 12541-12546.
47. Langklotz S, Narberhaus F, (2011) The Escherichia coli replication inhibitor CspD is subject to growth-regulated degradation by the Lon protease. Mol Microbiol 80: 1313-1325.
48. Kim Y, Wang X, Zhang XS, Grigoriu S, Page R, et al. (2010) Escherichia coli toxin/antitoxin pair MqsR/MqsA regulate toxin CspD. Environ Microbiol 12: 1105-1121.
49. Wagner S, Baars L, Ytterberg AJ, Klussmeier A, Wagner CS, et al. (2007) Consequences of membrane protein overexpression in Escherichia coli. Mol Cell Proteomics 6: 1527-1550.
50. Datsenko KA, Wanner BL, (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97: 6640-6645.
51. Pruteanu M, Neher SB, Baker TA, (2007) Ligand-controlled proteolysis of the Escherichia coli transcriptional regulator ZntR. J Bacteriol 189: 3017-3025.
52. Lundblad JR, Laurance M, Goodman RH, (1996) Fluorescence polarization analysis of protein-DNA and protein-protein interactions. Mol Endocrinol 10: 607-612.
53. Blattner FR, Plunkett G, 3rd, Bloch CA, Perna NT, Burland V, et al (1997) The complete genome sequence of Escherichia coli K-12. Science 277: 1453-1474.
54. Haldimann A, Wanner BL, (2001) Conditional-replication, integration, excision, and retrieval plasmid-host systems for gene structure-function studies of bacteria. J Bacteriol 183: 6384-6393.
55. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, et al. (2006) Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2: 2006.0008.
56. Kitagawa M, Ara T, Arifuzzaman M, Ioka-Nakamichi T, Inamoto E, et al. (2005) Complete set of ORF clones of Escherichia coli ASKA library (a complete set of E. coli K-12 ORF archive): unique resources for biological research. DNA Res 12: 291-299.
57. Ojangu EL, Tover A, Teras R, Kivisaar M, (2000) Effects of combination of different-10 hexamers and downstream sequences on stationary-phase-specific sigma factor sigma(S)-dependent transcription in Pseudomonas putida. J Bacteriol 182: 6707-6713.
58. Guzman LM, Belin D, Carson MJ, Beckwith J, (1995) Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol 177: 4121-4130.
59. Zaslaver A, Mayo AE, Rosenberg R, Bashkin P, Sberro H, et al. (2004) Just-in-time transcription program in metabolic pathways. Nat Genet 36: 486-491.